Natixis Cuts Stock Position in Cardinal Health, Inc. $CAH

Natixis lessened its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 45.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 86,051 shares of the company’s stock after selling 72,854 shares during the quarter. Natixis’ holdings in Cardinal Health were worth $14,457,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in the business. Atlantic Edge Private Wealth Management LLC lifted its holdings in Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares in the last quarter. Vermillion & White Wealth Management Group LLC raised its stake in shares of Cardinal Health by 55.0% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 71 shares in the last quarter. NewSquare Capital LLC boosted its holdings in Cardinal Health by 100.0% in the second quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after purchasing an additional 107 shares during the period. AlphaCore Capital LLC acquired a new position in Cardinal Health during the 2nd quarter worth $41,000. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in Cardinal Health in the 2nd quarter valued at about $47,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $198.48 on Tuesday. Cardinal Health, Inc. has a 1-year low of $114.60 and a 1-year high of $214.93. The business’s fifty day moving average price is $183.47 and its two-hundred day moving average price is $165.54. The company has a market capitalization of $47.16 billion, a P/E ratio of 29.94, a PEG ratio of 1.45 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The company had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same period last year, the company earned $1.88 earnings per share. The company’s quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio is currently 30.77%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CAH shares. TD Cowen boosted their price objective on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Evercore ISI lifted their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research report on Friday, October 31st. Barclays started coverage on Cardinal Health in a report on Monday. They issued an “overweight” rating and a $243.00 target price on the stock. Finally, Leerink Partners raised their price target on Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research note on Monday, November 17th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $209.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.